Ciliary Body Melanoma

Symptoms

Common signs and symptoms of Ciliary Body Melanoma include:

Blurred or distorted vision in one eye

Gradual loss of peripheral vision

Dark spots or shadows in vision

Changes in the shape of the pupil

Bulging or protrusion of the eye

Increased eye pressure or glaucoma

Pain or discomfort in the affected eye

Sensitivity to light

Seeing flashing lights or floaters

Double vision or diplopia

Visible dark growth on the iris edge

Sudden onset of severe vision loss

When to see a doctor

If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.

Causes & Risk Factors

Several factors can contribute to Ciliary Body Melanoma.

The exact cause of ciliary body melanoma remains largely unknown to medical researchers.

The exact cause of ciliary body melanoma remains largely unknown to medical researchers. Unlike skin melanoma, which has clear links to ultraviolet radiation exposure, ciliary body melanoma develops in an area of the eye that receives no direct sunlight. Scientists believe these tumors arise when melanocytes, the pigment-producing cells in the ciliary body, undergo genetic mutations that cause them to grow and divide uncontrollably. These mutations appear to happen randomly rather than from any specific environmental trigger.

Researchers have identified several genetic changes associated with uveal melanomas, including mutations in genes called BAP1, SF3B1, and EIF1AX.

Researchers have identified several genetic changes associated with uveal melanomas, including mutations in genes called BAP1, SF3B1, and EIF1AX. These genetic alterations affect how cells regulate their growth and death, allowing abnormal cells to survive and multiply. Some people may inherit genetic variations that make them more susceptible to developing these mutations, though ciliary body melanoma rarely runs in families like some other cancers do.

Certain underlying conditions may create an environment where melanoma is more likely to develop.

Certain underlying conditions may create an environment where melanoma is more likely to develop. People with ocular melanocytosis, a condition causing increased pigmentation in the eye, face a higher risk. Similarly, individuals with dysplastic nevus syndrome, characterized by atypical moles throughout the body, may have an elevated risk of developing uveal melanomas. However, most people who develop ciliary body melanoma have no identifiable predisposing factors, making prevention strategies particularly challenging.

Risk Factors

Light-colored eyes (blue, green, or hazel)
Fair skin that burns easily
Age over 50 years
Caucasian or European ancestry
Family history of melanoma
Ocular melanocytosis or increased eye pigmentation
Dysplastic nevus syndrome
Pre-existing iris or choroidal nevi
Welding or occupational UV exposure
Living at high altitudes with intense sunlight

Diagnosis

How healthcare professionals diagnose Ciliary Body Melanoma:

1
Diagnosing ciliary body melanoma requires sophisticated imaging techniques and specialized expertise because the tumor hides behind the iris where direct visualization is difficult.
Diagnosing ciliary body melanoma requires sophisticated imaging techniques and specialized expertise because the tumor hides behind the iris where direct visualization is difficult. The diagnostic process typically begins when patients report vision changes to their eye doctor or during routine eye examinations. Ophthalmologists use dilating drops to widen the pupil and examine the back of the eye with specialized lenses, though ciliary body tumors may still remain partially hidden from view.
2
Advanced imaging plays a crucial role in confirming the diagnosis.
Advanced imaging plays a crucial role in confirming the diagnosis. Ultrasound of the eye, called ocular ultrasonography, can detect masses in the ciliary body and measure their size and characteristics. This painless test uses sound waves to create detailed images of internal eye structures. Fluorescein angiography involves injecting a special dye into the bloodstream and photographing how it flows through blood vessels in the eye, helping doctors identify abnormal circulation patterns around tumors. Optical coherence tomography (OCT) provides high-resolution cross-sectional images of eye tissues.
3
Additional tests help determine the tumor's extent and plan treatment.
Additional tests help determine the tumor's extent and plan treatment. MRI scans of the head and orbits can show whether the cancer has spread beyond the eye into surrounding tissues. CT scans of the chest and abdomen check for metastases to other organs, particularly the liver where uveal melanomas commonly spread. Some centers use fine needle aspiration biopsy to obtain tissue samples for genetic testing, which helps predict the tumor's behavior and likelihood of spreading. Blood tests may include liver function studies since uveal melanomas have a tendency to metastasize to the liver.

Complications

The most immediate complication of ciliary body melanoma involves progressive vision loss in the affected eye.
As tumors grow, they can disrupt the ciliary body's normal functions of producing aqueous humor and controlling lens focus, leading to increased eye pressure, glaucoma, and eventual blindness.
Large tumors may cause the lens to dislocate or the retina to detach, resulting in sudden severe vision loss.
Some patients develop chronic pain, inflammation, or bleeding within the eye that significantly impacts quality of life.
The most serious long-term complication is metastatic spread, which occurs in approximately 25-50% of ciliary body melanoma patients within 10-15 years of diagnosis.
Unlike skin melanomas that can spread to various organs, uveal melanomas show a strong tendency to metastasize to the liver first, often years after the initial eye treatment.
Lung, bone, and skin metastases may also occur.
Unfortunately, once uveal melanoma spreads beyond the eye, treatment options become limited and survival rates decline significantly.
Regular monitoring with liver imaging and blood tests helps detect metastases early when treatment options may be more effective.

Prevention

Preventing ciliary body melanoma presents significant challenges because researchers haven't identified clear environmental causes like those established for skin melanoma.
Unlike skin cancer prevention, which focuses heavily on sun protection, ciliary body melanoma develops in eye structures that receive no direct ultraviolet exposure.
However, some general protective measures may help reduce risk, though their effectiveness specifically for ciliary body melanoma remains unproven.
Regular eye examinations represent the most practical preventive strategy, allowing for early detection when tumors are smaller and more treatable.
Adults should have comprehensive eye exams every 1-2 years, particularly those over age 50 or with risk factors like light-colored eyes or family history of melanoma.
People with known ocular melanocytosis or suspicious eye spots should follow their ophthalmologist's recommended surveillance schedule, which may include more frequent monitoring.
General cancer prevention strategies may provide some benefit, though their specific impact on ciliary body melanoma is uncertain.
Protecting the eyes from intense UV radiation with quality sunglasses might help, especially for people who work outdoors or at high altitudes.
Maintaining overall health through a balanced diet rich in antioxidants, regular exercise, and avoiding smoking supports the immune system's ability to detect and eliminate abnormal cells.
While these measures can't guarantee prevention, they contribute to overall health and may reduce cancer risk in general.

Treatment Approaches

Treatment for ciliary body melanoma depends on the tumor's size, location, and genetic characteristics, with the primary goals being cancer control and vision preservation when possible.

Treatment for ciliary body melanoma depends on the tumor's size, location, and genetic characteristics, with the primary goals being cancer control and vision preservation when possible. Small tumors may be monitored closely with regular imaging if they appear stable and aren't causing significant symptoms. This approach, called active surveillance, involves frequent eye exams and ultrasounds every 3-6 months to watch for growth or changes that would trigger more aggressive treatment.

Radiation therapy represents the most common treatment for medium-sized ciliary body melanomas.

Radiation therapy represents the most common treatment for medium-sized ciliary body melanomas. Plaque brachytherapy involves surgically placing a small radioactive disc directly on the eye wall next to the tumor for several days, delivering focused radiation while minimizing exposure to surrounding healthy tissues. Proton beam radiation offers another precise option, using charged particles to target the tumor with millimeter accuracy over multiple treatment sessions. Both radiation approaches can effectively control many ciliary body melanomas while preserving the eye structure.

SurgicalTherapyOncology

Surgical options range from tumor removal to complete eye removal depending on the clinical situation.

Surgical options range from tumor removal to complete eye removal depending on the clinical situation. Local resection attempts to remove just the tumor and surrounding tissue while preserving the eye, though this challenging procedure requires specialized expertise and isn't suitable for all tumor locations. Enucleation, or surgical removal of the entire eye, may be necessary for large tumors, those causing severe pain, or when other treatments have failed. Modern prosthetic eyes can provide excellent cosmetic results after enucleation.

Surgical

Systemic therapy becomes important if the cancer spreads beyond the eye or shows high-risk genetic features.

Systemic therapy becomes important if the cancer spreads beyond the eye or shows high-risk genetic features. Immunotherapy drugs like pembrolizumab and nivolumab have shown promise in treating metastatic uveal melanoma. Targeted therapies that block specific molecular pathways are being studied in clinical trials. Liver-directed treatments, including surgical resection, ablation, or isolated hepatic perfusion, may help control metastases since the liver is the most common site of uveal melanoma spread.

SurgicalMedicationTherapy

Living With Ciliary Body Melanoma

Living with ciliary body melanoma requires adapting to potential vision changes while managing the emotional impact of a cancer diagnosis. Many patients successfully adjust to vision loss in one eye, though depth perception and peripheral vision may be affected. Practical modifications can help maintain independence and safety, including using extra lighting for reading, being cautious with stairs and curbs, and positioning computer screens and reading materials to maximize remaining vision. Occupational therapists can provide valuable strategies for adapting daily activities.

The psychological aspects of ciliary body melanoma often prove as challenging as the physical effects.The psychological aspects of ciliary body melanoma often prove as challenging as the physical effects. Anxiety about cancer spread, grief over vision loss, and uncertainty about the future are normal responses that benefit from professional support. Many patients find counseling helpful, whether individual therapy, support groups, or connecting with other eye cancer survivors. Organizations like the Ocular Melanoma Foundation provide resources, educational materials, and peer support networks specifically for people affected by eye melanomas.

Regular follow-up care becomes a lifelong commitment for ciliary body melanoma survivors.Regular follow-up care becomes a lifelong commitment for ciliary body melanoma survivors. This typically includes eye exams every 3-6 months initially, then annually, plus liver monitoring through blood tests and imaging every 6-12 months to watch for metastases. Many patients find it helpful to maintain a health journal tracking symptoms, vision changes, and appointment schedules. Staying informed about new treatments and clinical trials can provide hope and additional options if the cancer progresses. Most importantly, focusing on maintaining overall health, relationships, and activities that bring joy helps people live full lives despite the challenges of this rare cancer.

Latest Medical Developments

Latest medical developments are being researched.

Frequently Asked Questions

How is ciliary body melanoma different from regular skin melanoma?

Ciliary body melanoma develops inside the eye in an area that never receives sunlight, unlike skin melanoma which is strongly linked to UV exposure. Eye melanomas also have different genetic patterns and a higher tendency to spread specifically to the liver rather than multiple organs like skin melanomas.

Will I definitely lose my vision if I have ciliary body melanoma?

Not necessarily. Vision outcomes depend on tumor size, location, and treatment chosen. Some small tumors can be monitored without immediate vision loss, while radiation treatments may preserve useful vision in many cases.

Can ciliary body melanoma spread to my other eye?

No, ciliary body melanoma very rarely spreads to the other eye. However, people who develop one eye melanoma have a slightly higher risk of developing a separate new melanoma in the other eye over many years.

How often will I need follow-up appointments after treatment?

Initially, you'll need eye exams every 3-6 months and liver monitoring every 6-12 months. The frequency may decrease over time, but lifelong surveillance is necessary because metastases can occur years after the initial treatment.

Is ciliary body melanoma hereditary?

Most cases are not hereditary, though having light-colored eyes or fair skin (which can be inherited) may increase risk slightly. Family history of any type of melanoma might pose a small additional risk.

Can I drive safely with vision in only one eye?

Many people adapt well to driving with one eye, though you'll need time to adjust to changes in depth perception and peripheral vision. Check with your eye doctor and local DMV about any vision requirements or restrictions.

Are there any new treatments being developed?

Yes, researchers are studying immunotherapy drugs, targeted therapies based on genetic testing, and new radiation techniques. Clinical trials are available for both primary eye tumors and metastatic disease.

What symptoms should I watch for that might indicate the cancer has spread?

Watch for abdominal pain, unexplained weight loss, yellowing of skin or eyes, persistent fatigue, or new lumps under the skin. Regular blood tests and imaging help detect spread before symptoms appear.

Will radiation treatment be painful?

Plaque brachytherapy requires surgery to place and remove the radioactive plaque, which involves some discomfort. Proton beam therapy is painless during treatment but may cause temporary eye irritation afterward.

Should I avoid certain activities or foods after diagnosis?

No specific dietary restrictions are necessary, though maintaining good overall nutrition supports healing. Avoid activities that might injure the affected eye, and follow your doctor's guidance about exercise and travel.

Update History

Apr 3, 2026v1.0.0

Published by DiseaseDirectory